Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,048 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.
Padron E, Garcia-Manero G, Patnaik MM, Itzykson R, Lasho T, Nazha A, Rampal RK, Sanchez ME, Jabbour E, Al Ali NH, Thompson Z, Colla S, Fenaux P, Kantarjian HM, Killick S, Sekeres MA, List AF, Onida F, Komrokji RS, Tefferi A, Solary E. Padron E, et al. Among authors: kantarjian hm. Blood Cancer J. 2015 Jul 31;5(7):e333. doi: 10.1038/bcj.2015.53. Blood Cancer J. 2015. PMID: 26230957 Free PMC article.
The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations.
Verschraegen CF, Kantarjian HM, Hirsch-Ginsberg C, Lee MS, O'Brien S, Rios MB, Stass SA, Keating M, Talpaz M. Verschraegen CF, et al. Among authors: kantarjian hm. Cancer. 1995 Sep 15;76(6):992-7. doi: 10.1002/1097-0142(19950915)76:6<992::aid-cncr2820760612>3.0.co;2-l. Cancer. 1995. PMID: 8625225
The hyper-CVAD regimen in adult acute lymphocytic leukemia.
Garcia-Manero G, Kantarjian HM. Garcia-Manero G, et al. Among authors: kantarjian hm. Hematol Oncol Clin North Am. 2000 Dec;14(6):1381-96, x-xi. doi: 10.1016/s0889-8588(05)70192-1. Hematol Oncol Clin North Am. 2000. PMID: 11147229 Review.
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation.
Giles FJ, Kantarjian HM, Kornblau SM, Thomas DA, Garcia-Manero G, Waddelow TA, David CL, Phan AT, Colburn DE, Rashid A, Estey EH. Giles FJ, et al. Among authors: kantarjian hm. Cancer. 2001 Jul 15;92(2):406-13. doi: 10.1002/1097-0142(20010715)92:2<406::aid-cncr1336>3.0.co;2-u. Cancer. 2001. PMID: 11466696
1,048 results